Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dazoxiben (CAS 78218-09-4)

5.0(1)
Write a reviewAsk a question

CAS Number:
78218-09-4
Molecular Weight:
232.24
Molecular Formula:
C12H12N2O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Dazoxiben, a pharmaceutical compound, falls under the category of thromboxane synthase inhibitors. With its potent inhibitory properties, it effectively hampers the synthesis of thromboxane A2 (TXA2), a formidable vasoconstrictor and platelet aggregator. By targeting thromboxane synthase, the enzyme responsible for the synthesis of thromboxane A2 from prostaglandin H2 (PGH2), dazoxiben successfully curtails its production


Dazoxiben (CAS 78218-09-4) References

  1. Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel.  |  Sathler, PC., et al. 2014. J Enzyme Inhib Med Chem. 29: 527-31. PMID: 23914925
  2. The effects of dazoxiben, an inhibitor of thromboxane synthetase, on cold-induced forearm vasoconstriction and platelet behaviour in different individuals.  |  Cowley, AJ., et al. 1985. Br J Clin Pharmacol. 19: 1-8. PMID: 2983748
  3. Aspirin and dazoxiben as inhibitors of platelet behaviour: modification of their effects by agents that alter cAMP production.  |  Sills, T., et al. 1986. Thromb Res. 42: 91-8. PMID: 3010495
  4. Metabolic protection of the reperfused canine endocardium by the thromboxane synthetase inhibitor, dazoxiben.  |  Pieper, GM., et al. 1988. Prostaglandins Leukot Essent Fatty Acids. 33: 13-22. PMID: 3054935
  5. Indomethacin, dazoxiben and extravascular lung water after Escherichia coli infusion.  |  Price, S., et al. 1986. J Surg Res. 41: 189-97. PMID: 3093772
  6. Dazoxiben-induced changes in the thromboxane/prostacyclin balance in the lateral cochlear wall of the guinea pig.  |  Ernst, A., et al. 1988. Arch Otorhinolaryngol. 245: 50-2. PMID: 3291841
  7. Raised plasma thromboxane B2 levels in experimental acute necrotizing pancreatitis in rats. The effects of flunarizine, dazoxiben, and indomethacin.  |  van Ooijen, B., et al. 1988. Scand J Gastroenterol. 23: 188-92. PMID: 3363291
  8. Dazoxiben, a prototype inhibitor of thromboxane synthesis, has little toxicity in laboratory animals.  |  Irisarri, E., et al. 1985. Hum Toxicol. 4: 311-5. PMID: 4040117
  9. Selective inhibition of thromboxane synthesis with dazoxiben in animals and man.  |  Randall, MJ. 1983. Thromb Res Suppl. 4: 81-5. PMID: 6415861
  10. Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon.  |  Luderer, JR., et al. 1984. Clin Pharmacol Ther. 36: 105-15. PMID: 6428793
  11. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.  |  Patrignani, P., et al. 1984. J Pharmacol Exp Ther. 228: 472-7. PMID: 6537977
  12. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.  |  Bush, LR., et al. 1984. Circulation. 69: 1161-70. PMID: 6546902
  13. Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.  |  Burke, SE., et al. 1983. Br J Clin Pharmacol. 15 Suppl 1: 97S-101S. PMID: 6681711

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Dazoxiben, 25 mg

sc-492401
25 mg
$290.00